ReviewFrontiers in cardiovascular medicine2022

Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure.

Sheldon E Litwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.